The authors reply: Letter on: "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy" by Zhou et al. Issue 5 (23rd July 2020) - Zhou, Haiyan; Muntoni, Francesco